Smac/DIABLO is not released from mitochondria during apoptotic signalling in cells deficient in cytochrome c

T M Hansen1, D J Smith, P Nagley

  • 1Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia.

Insights

Mitochondria normally release cytochrome c and Smac/DIABLO together during apoptosis. However, cells lacking cytochrome c fail to release Smac/DIABLO, revealing a new link in apoptosis regulation.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Cytochrome c release from mitochondria is a key event in apoptosis.
  • Smac/DIABLO is another mitochondrial protein released during apoptosis, promoting cell death.
  • The coordinated release of these proteins is crucial for the apoptotic pathway.

Purpose of the Study:

  • To investigate the role of cytochrome c in the release of Smac/DIABLO during apoptosis.
  • To characterize the apoptotic defects in cells lacking cytochrome c.
  • To understand the relationship between cytochrome c and Smac/DIABLO release.

Main Methods:

  • Confocal microscopy to visualize protein localization.
  • Western blotting to detect protein levels.
  • Induction of apoptosis using staurosporine (STS).
  • Analysis of cytochrome c-null (cyt c-/-) cells and control cells.

Main Results:

  • Cells lacking cytochrome c (cyt c-/-) showed Bax translocation to mitochondria and activation upon STS treatment.
  • However, cyt c-/- cells failed to release Smac/DIABLO from mitochondria.
  • Control cells expressing cytochrome c successfully released both cytochrome c and Smac/DIABLO.
  • Proteasomal degradation of cytosolic Smac/DIABLO was ruled out as the cause of its absence.

Conclusions:

  • There is an unexpected link between cytochrome c and Smac/DIABLO release from mitochondria.
  • The release of these two proteins, previously thought to be simultaneous, is differentially regulated.
  • The inability of cyt c-/- cells to release Smac/DIABLO highlights distinct regulatory mechanisms for mitochondrial protein release in apoptosis.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.